How to Manage COVID-19 Vaccination in Immune-Mediated Inflammatory Diseases: An Expert Opinion by IMIDs Study Group

被引：28

作者：

Ferretti, Francesca ^{[1
]}

Cannatelli, Rosanna ^{[1
]}

Benucci, Maurizio ^{[2
]}

Carmagnola, Stefania ^{[1
]}

Clementi, Emilio ^{[3
,4
]}

Danelli, Piergiorgio ^{[5
]}

Dilillo, Dario ^{[6
]}

Fiorina, Paolo ^{[7
,8
,9
]}

Galli, Massimo ^{[10
]}

Gallieni, Maurizio ^{[11
,12
]}

Genovese, Giovanni ^{[1
,13
,14
]}

Giorgi, Valeria ^{[15
]}

Invernizzi, Alessandro ^{[16
,17
]}

Maconi, Giovanni ^{[1
]}

Maier, Jeanette A. ^{[11
]}

Marzano, Angelo V. ^{[14
]}

Morpurgo, Paola S. ^{[7
]}

Nebuloni, Manuela ^{[18
]}

Radovanovic, Dejan ^{[19
]}

Riva, Agostino ^{[11
]}

Rizzardini, Giuliano ^{[20
,21
]}

Sabiu, Gianmarco ^{[11
]}

Santus, Pierachille ^{[11
,19
]}

Staurenghi, Giovanni ^{[16
]}

Zuccotti, Gianvincenzo ^{[6
]}

Sarzi-Puttini, Pier Carlo ^{[15
]}

Ardizzone, Sandro ^{[1
]}

机构：

[1] Univ Milan, Dept Biomed & Clin Sci DIBIC L Sacco, Gastroenterol Unit, ASST Fatebenefratelli Sacco, Milan, Italy

[2] S Giovanni Dio Hosp, Rheumatol Unit, Azienda USL Toscana Ctr, Florence, Italy

[3] Univ Milan, Dept Biomed & Clin Sci DIBIC L Sacco, Unit Clin Pharmacol, Milan, Italy

[4] Sci Inst IRCCS E Medea, Lecce, Italy

[5] Univ Milan, Dept Biomed & Clin Sci DIBIC L Sacco, Surg Unit, ASST Fatebenefratelli Sacco, Milan, Italy

[6] Univ Milan, Pediat Dept, Dept Biomed & Clin Sci DIBIC L Sacco, Osped Bambini,ASST Fatebenefratelli Sacco, Milan, Italy

[7] ASST Fatebenefratelli Sacco, Div Endocrinol, Milan, Italy

[8] Univ Milan, Int Ctr T1D, Pediat Clin Res Ctr Romeo & Enrica Invernizzi, DIBIC, Milan, Italy

[9] Harvard Med Sch, Boston Childrens Hosp, Nephrol Div, Boston, MA 02115 USA

[10] Univ Milan, Univ Hosp Luigi Sacco, Dept Biomed & Clin Sci DIBIC L Sacco, Infect Dis Unit 3, Milan, Italy

[11] Univ Milan, Dept Biomed & Clin Sci DIBIC L Sacco, Milan, Italy

[12] L Sacco Hosp Vialba, Nephrol & Dialysis Unit, ASST Fatebenefratelli Sacco, Milan, Italy

[13] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy

[14] Univ Milan, Dermatol Unit, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy

[15] Univ Milan, Dept Biomed & Clin Sci DIBIC L Sacco, Rheumatol Unit, Milan, Italy

[16] Univ Milan, Dept Biomed & Clin Sci Luigi Sacco, Eye Clin, Milan, Italy

[17] Univ Sydney, Save Sight Inst, Sydney Med Sch, Discipline Ophthalmol, Sydney, NSW, Australia

[18] Univ Milan, Dept Biomed & Clin Sci DIBIC L Sacco, Pathol Unit, Milan, Italy

[19] Osped L Sacco, Div Resp Dis, ASST Fatebenefratelli Sacco, Milan, Italy

[20] Univ Milan, Dept Infect Dis, ASST Fatebenefratelli Sacco, Milan, Italy

[21] Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Johannesburg, South Africa

来源：

FRONTIERS IN IMMUNOLOGY | 2021年 / 12卷

关键词：

COVID-19; Sars-CoV-2; vaccine; IMIDs; chronic disease; prevention; EFFICACY; RISK;

D O I：

10.3389/fimmu.2021.656362

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Since March 2020, the outbreak of Sars-CoV-2 pandemic has changed medical practice and daily routine around the world. Huge efforts from pharmacological industries have led to the development of COVID-19 vaccines. In particular two mRNA vaccines, namely the BNT162b2 (Pfizer-BioNTech) and the mRNA-1273 (Moderna), and a viral-vectored vaccine, i.e. ChAdOx1 nCoV-19 (AstraZeneca), have recently been approved in Europe. Clinical trials on these vaccines have been published on the general population showing a high efficacy with minor adverse events. However, specific data about the efficacy and safety of these vaccines in patients with immune-mediated inflammatory diseases (IMIDs) are still lacking. Moreover, the limited availability of these vaccines requires prioritizing some vulnerable categories of patients compared to others. In this position paper, we propose the point of view about the management of COVID-19 vaccination from Italian experts on IMIDs and the identification of high-risk groups according to the different diseases and their chronic therapy.

引用

页数：14

共 50 条

[21] COVID-19 vaccination in patients with immune-mediated inflammatory diseases receiving rituximab: A personalized regimen should be formulated
Yang, Qian
Jiang, Qi
Niu, Man Man
Fan, Guo Zhen
Hu, Peng
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (01) : E45 - E46
[22] IMID-Biobank: Biobank of immune-mediated inflammatory diseases (IMIDs)
S Marsal
J Cañete
J Tornero
A Fernandez-Nebro
J M Hernanz
J Panes
A Julià
R Tortosa
Journal of Translational Medicine, 8 (Suppl 1)
[23] Immune-mediated inflammatory diseases (IMIDs) and biologic therapy:: a medical revolution
Kuek, Annabel
Hazleman, Brian L.
Oestoer, Andrew J. K.
POSTGRADUATE MEDICAL JOURNAL, 2007, 83 (978) : 251 - 260
[24] Type 1 interferons: A target for immune-mediated inflammatory diseases (IMIDs)
Mathian, Alexis
Felten, Renaud
Alarcon-Riquelme, Marta E.
Psarras, Antony
Mertz, Philippe
Chasset, Francois
Vital, Edward M.
Arnaud, Laurent
JOINT BONE SPINE, 2024, 91 (02)
[25] COVID-19 and immune-mediated inflammatory diseases: effect of disease and treatment on COVID-19 outcomes and vaccine responses
Fagni, Filippo
Simon, David
Tascilar, Koray
Schoenau, Verena
Sticherling, Michael
Neurath, Markus F.
Schett, Georg
LANCET RHEUMATOLOGY, 2021, 3 (10): : E724 - E736
[26] Immune-mediated liver injury following COVID-19 vaccination
Georgios Schinas
Eleni Polyzou
Vasiliki Dimakopoulou
Stamatia Tsoupra
Charalambos Gogos
Karolina Akinosoglou
World Journal of Virology, 2023, (02) : 100 - 108
[27] COVID-19 vaccine confidence in the post-vaccination era: Perceptions among adults with immune-mediated inflammatory diseases
Santana, F. M.
Rezende, R. P. V.
Paschoal, N. O. S.
Rocha, L. F.
Lopes, J. B.
Perez, M. O.
Bunjes, B. G.
Dorio, M.
Furquim, M. A. D.
Cobra, J. F.
Sales, L. P.
Figueiredo, C. P.
PUBLIC HEALTH IN PRACTICE, 2023, 6
[28] Covid-19 in Immune-Mediated Inflammatory Diseases - Case Series from New York
Haberman, Rebecca
Axelrad, Jordan
Chen, Alan
Castillo, Rochelle
Yan, Di
Izmirly, Peter
Neimann, Andrea
Adhikari, Samrachana
Hudesman, David
Scher, Jose U.
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (01): : 85 - 88
[29] Immunogenicity and Efficacy of Mixed COVID-19 Vaccine Regimens in Immune-Mediated Inflammatory Diseases
Hitchon, Carol
Mesa, Christine
Bernstein, Charles
Card, Catherine
Marrie, Ruth
OBrien, Sheila
Kim, John
JOURNAL OF RHEUMATOLOGY, 2023, 50 (07) : 49 - 50
[30] Direct and Indirect Impact of COVID-19 for Patients with Immune-Mediated Inflammatory Diseases: A Retrospective Cohort Study
Belleudi, Valeria
Rosa, Alessandro C.
Poggi, Francesca R.
Armuzzi, Alessandro
Nicastri, Emanuele
Goletti, Delia
Diamanti, Andrea Picchianti
Davoli, Marina
Agabiti, Nera
Addis, Antonio
JOURNAL OF CLINICAL MEDICINE, 2021, 10 (11)

← 1 2 3 4 5 →